Q1 · MEDICINE
Article
Author: Czestkowski, Wojciech ; Koralewski, Robert ; Siwińska, Anna ; Lisiecka, Katarzyna ; Niedziałek, Dorota ; Mulewski, Krzysztof ; Piwowar, Katarzyna ; Nowotny, Marcin ; Olczak, Jacek ; Pluta, Elżbieta ; Drzewicka, Katarzyna ; Bartoszewicz, Agnieszka ; Olejniczak, Sylwia ; Nowak, Elżbieta ; Papiernik, Diana ; Matyszewski, Krzysztof ; Gołębiowski, Adam ; Zasłona, Zbigniew ; Jędrzejczak, Karol ; Kozieł, Rafał ; Kowalski, Michał ; Wieczorek, Grzegorz ; Napiórkowska-Gromadzka, Agnieszka ; Piotrowicz, Michał C. ; Mazur, Marzena ; Krzemiński, Łukasz ; Rejczak, Tomasz ; Andryianau, Gleb
Chitinase-3-like-1 (CHI3L1), also known as YKL-40, is a glycoprotein linked to inflammation, fibrosis, and cancer. This study explored CHI3L1's interactions with various oligosaccharides using microscale thermophoresis (MST) and AlphaScreen (AS). These investigations guided the development of high-throughput screening assays to assess interference of small molecules in binding between CHI3L1 and biotinylated small molecules or heparan sulfate-based probes. Small molecule binders of YKL-40 were identified in our chitotriosidase inhibitors library with MST and confirmed through X-ray crystallography. Based on cocrystal structures of potent hit compounds with CHI3L1, small molecule probes 19 and 20 were designed for an AS assay. Structure-based optimization led to compounds 30 and 31 with nanomolar activities and drug-like properties. Additionally, an orthogonal AS assay using biotinylated heparan sulfate as a probe was developed. The compounds' affinity showed a significant correlation in both assays. These screening tools and compounds offer novel avenues for investigating the role of CHI3L1.